Impact of geriatric impairments on outcomes of single-agent immunotherapy in solid tumors.
Saved in:
| Title: | Impact of geriatric impairments on outcomes of single-agent immunotherapy in solid tumors. |
|---|---|
| Authors: | Özkan A; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., de Joode K; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Slingerland M; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Zunder S; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., van den Bos F; Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands.; LUMC Center for Medicine for Older People, Leiden University Medical Center, Leiden, The Netherlands., Mooijaart S; Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands.; LUMC Center for Medicine for Older People, Leiden University Medical Center, Leiden, The Netherlands., Uit den Boogaard A; Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands.; LUMC Center for Medicine for Older People, Leiden University Medical Center, Leiden, The Netherlands., Trompet S; Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands.; LUMC Center for Medicine for Older People, Leiden University Medical Center, Leiden, The Netherlands., Westgeest H; Department of Medical Oncology, Amphia Hospital, Breda, The Netherlands., van der Veldt A; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands., Labots G; Department of Internal Medicine, Haga Hospital, The Hague, The Netherlands., Holterhues C; Department of Internal Medicine, Haga Hospital, The Hague, The Netherlands., Verdegaal EME; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., de Glas NA; Department of Medical Oncology, Helse Førde, Førde, Norway., Portielje JEA; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. |
| Source: | International journal of cancer [Int J Cancer] 2026 Mar 01; Vol. 158 (5), pp. 1370-1382. Date of Electronic Publication: 2025 Oct 04. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
